Stay updated on KN026 in Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the KN026 in Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KN026 in Metastatic Breast Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision: v3.5.0 has been added and v3.4.3 removed from the update log. This appears to be an internal site version update rather than a change to study content or user-facing features.
    Difference
    0.1%
    Check dated 2026-03-18T16:48:39.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3; the previous revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T14:54:58.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed Revision: v3.4.1; and replaced a government funding status notice. These changes affect page presentation and status messaging but do not alter trial data, eligibility, or outcomes shown on the page.
    Difference
    0.5%
    Check dated 2026-02-11T02:04:09.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    A government funding status notice and an NIH operating status banner were added, and the site revision note was updated to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-03T23:16:40.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Introduced Show glossary option and Revision: v3.4.0. Updated the QC-related label to 'Last Update Submitted that Met QC Criteria' and standardized capitalization for No FEAR Act data.
    Difference
    0.2%
    Check dated 2026-01-27T21:54:13.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The last known status line now indicates Jiangsu Alphamab Biopharmaceuticals Co., Ltd as of September 2023, with status marked as Verified and Unknown.
    Difference
    0.4%
    Check dated 2026-01-06T16:36:30.000Z thumbnail image

Stay in the know with updates to KN026 in Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KN026 in Metastatic Breast Cancer Clinical Trial page.